原标题：每经操盘必知（午间版）丨 CRO概念股重挫，药明康德等多公司最新回应；两架C919飞机飞抵首都国际机场每经编辑：彭水萍北京时间9月13日11:30，
上证指数早盘上涨10.67点，涨幅为0.33%，报收3272.72点，成交额2175.84亿元；
深证成指上涨75.4点，涨幅为0.63%，报收11953.19点，成交额2831.55亿元；
创业板指上涨7.9点，涨幅为0.3%，报收2556.12点，成交额842.03亿元；沪深300上涨28.83点，涨幅为0.7%，报收4122.62点，成交额1420.12亿元。
WASHINGTON -- Charles and Kathleen Moore are about to have their day in the Supreme Court over a $15,000 tax bill they contend is unconstitutional.The couple from Redmond, Washington, claim they had to pay the money because of their investment in an Indian company from which, as Charles Moore, 62, said in a sworn statement, they “have never received a distribution, dividend, or other payment.”But significant parts of the story they have told to reach this point seem at odds with public records.The Moores are the public face of a high court case backed by business and conservative political interests that could call into question other parts of the U.S. tax code and rule out a much-discussed but never-enacted tax on wealth. The case is set for arguments on Dec. 5. The Moores are the latest example of plaintiffs whose lawsuits seem to simply be exercising their legal rights, but whose cases are backed by others with enormous amounts of money or a consequential social issue at stake. The Moores sought help from the anti-regulatory Competitive Enterprise Institute.Underscoring the case's importance at a recent Heritage Foundation event, lawyer Paul Clement said, "The constitutionality of a wealth tax may well be decided in the context of this case.”Details of the Moores' involvement with the company, initially called KisanKraft Machine Tools Private Limited, were first reported by Tax Notes, which caters to tax professionals. The public documents are filings with the Indian government.At issue in the case is a provision of the 2017 tax bill enacted by a Republican-controlled Congress and signed by then-President Donald Trump. The law applies to companies that are owned by Americans, but do their business in foreign countries. It imposes a one-time tax on investors' shares of profits that have not been passed along to them, in order to offset other tax benefits. The measure is expected to generate $340 billion in tax revenues.The Moores, along with the U.S. Chamber of Commerce and conservative think tanks, contend that the provision violates the 16th Amendment, which allows the federal government to impose an income tax on Americans.The $15,000 tax bill was for the Moores' share of KisanKraft's profits."If you haven’t received any income, how can you be required to pay income taxes?” Charles Moore asks in a video posted by the Competitive Enterprise Institute.But far from being a passive investor with no influence over the company, Moore, who worked at Microsoft during his career in software development, served on KisanKraft's board of directors for five years.“The story the Moores told about Charles' involvement with KisanKraft is directly at odds with the fiduciary responsibilities of an individual holding a board seat for an Indian company,” Mindy Herzfeld, a professor of tax practice at the University of Florida law school, wrote in Tax Notes.And there are other indications of Moore's more extensive involvement with KisanKraft than his testimony indicated. The company paid for his travel to India four times and he made at least two investments beyond the $40,000 stake he put up in 2006.Moore also was prepared to invest an another roughly $250,000. That money was ultimately returned by KisanKraft, along with 12% interest.One other inconsistency is that while the Moores say they jointly invested the money, only Charles Moore's name appears in company documents.The couple and their lawyers did not disclose any of that information in legal filings in three different federal courts, including the Supreme Court.“The original declaration on which the case is built is full of lies,” said Reuven Avi-Yonah, an international tax expert at the University of Michigan law school.In a brief conversation with The Associated Press, Kathleen Moore said she and her husband would not discuss the case and referred questions to their lawyers. Andrew Grossman, the Moore's lead attorney, did not respond to messages seeking comment.The omissions, along with the Moores' failure to take advantage of other legal options that would have deferred, if not eliminated, their tax liability make Avi-Yonah and other experts in international tax law suspect the case was manufactured to get at a larger issue, the tax on billionaires that has been proposed by some prominent Democrats but never enacted.A wealth tax would apply not to the incomes of the very richest Americans, but their assets, like stock holdings, that now only get taxed when they are sold. “There really was no reason for the court to take it on, other than to send a signal to warn off the Congress from passing a billionaire tax," said Steven Rosenthal, a senior fellow at the Urban-Brookings Tax Policy Center.Other provisions of the tax code could be upended by the court's decision, including measures relating to partnerships, limited liability companies and other business formations, Rosenthal said.Changes to those provisions also could affect some justices' finances. Chief Justice John Roberts holds a one-eighth interest worth up to $15,000 in an Irish partnership that owns a cottage in county Limerick, Ireland, and Justice Clarence Thomas' wife, Ginni, owns a limited liability company that generated between $50,000 and $100,000 in income last year from Nebraska real estate, according to the justices' financial disclosure forms. Two other recent Supreme Court cases advanced by conservative interests also raised questions about whether facts had been manipulated to get the disputes in front of the court. One of those involved a wedding website designer in Colorado who did not want to work with same-sex couples and a public high school football coach in Washington who wanted to pray on the field.Rosenthal said that “the ugly facts matter” and that the justices could return the Moores' case to a lower court without ruling on it.Charles Moore said in his sworn statement that he agreed to invest in the company that was being formed by his friend and former colleague at Microsoft, Ravindra “Ravi” Kumar Agrawal, because he liked the business plan and trusted his friend.“Moreover, I thought KisanKraft was formed for a noble purpose and had the potential to improve the lives of small and marginal farmers in India,” Moore said. The case had already kicked up ethical questions. Senate Democrats had asked Justice Samuel Alito to step aside from the case because of his interactions with David Rivkin, another lawyer who also is representing the Moores. The Democrats said Alito had cast doubt on his ability to judge the case fairly because he sat for four hours of Wall Street Journal opinion page interviews with an editor at the newspaper and Rivkin.Alito rejected the demands in a four-page statement issued by the court in which he said there “is no valid reason” for his recusal. ___Associated Press writer Fatima Hussein contributed to this report.___This story has been corrected to reflect that Mindy Herzfeld is a professor of tax practice at the University of Florida law school, not director of the master's program in international tax.。
二 | 个股涨多跌少，两市超2800只个股上涨。沪深两市半日成交额达5008亿，较上个交易日上午缩量21亿。北向资金方面，沪股通早盘净流入7.99亿，深股通早盘净流入21.13亿。盘面上，贵金属板块大涨，金贵银业涨停，赤峰黄金创阶段新高。养殖板块震荡走强，天邦食品领涨。汽车整车股盘中异动，亚星客车涨停。此外中药、白酒、油气等板块均有所活跃，但大多数个股均冲高回落。
三 | 整体上市场热点较为杂乱，无特别强势的主线。下跌方面，CRO概念股重挫，康龙化成、药石科技跌超10%，凯莱英跌停。涨幅前五的行业分别是采掘行业3.07%、贵金属2.68%、农牧饲渔2.39%、汽车整车2.24%、酿酒行业1.91%。跌幅前五的行业分别是电力行业-1.85%、风电设备-1.64%、房地产开发-1.44%、光伏设备-1.39%、燃气-1.33%。、9月13日早盘，主力资金净流入有色、农业、银行、白酒等板块，净流出医药、电力、煤炭、光伏等板块。个股净流入方面，西藏矿业、招商银行、贵州茅台获净流入6.91亿元、5.66亿元、5.53亿元。净流出方面，药明康德、粤宏远A、凯莱英遭抛售8.73亿元、3.58亿元、3.26亿元。NO.1 近日，网传北京市管企业收到北京国资委通知，梳理与复星集团的合作情况（不限于持有股票，股权投资，资金出借，工程承包，担保，商贸合作等事项），并研判相关合作风险，形成书面报告。
四 | 对此，复星集团回应称：我们留意到有网传“北京市国资委通知”。经向北京国资委问询，获悉这一调研是北京市国资委系统的一项日常信息搜集工作，没有任何针对性，此前他们也对有关企业发过相关调研通知。复星在北京各项业务发展正常。8月31日公司刚发布半年报，在当前宏观环境复杂多变的背景下，依旧保持稳健和韧劲，各项业务平稳运行。(第一财经)NO.2 受美国准备签署行政法令，帮助扩大美国生物制造业消息的影响，A股市场的CXO、CDMO概念股大跌。其中，凯莱英、药明康德跌停，康龙化成、药石科技跌幅超过10%，泰格医药也一度逼近跌停。对此，泰格医药方面表示，从目前公开消息来看，主要针对的是临床前CRO业务，对泰格医药目前业务没有影响，公司不涉及CDMO和生物医药业务。(证券时报)NO.3 9月13日上午，CXO概念板块大跌，凯莱英跌停，药明康德、九洲药业逼近跌停，康龙化成跌超11%。消息称美国总统拜登准备签署一项行政命令，帮助扩大美国的生物制造业，减少对于中国的依赖。药明康德人士9月13日上午向记者表示，公司也关注到上述信息，“公司业务和运营一切正常。”（证券时报）NO.4 记者以投资者身份从博腾股份证券部获悉：“目前行政命令还没有更多实施细则，至少短期内没有看到对我们业务有实质性影响，因为医药制造行业不是突然说转就能转，还涉及很多法规。长期来看，公司肯定会有一些应对措施，因为我们本来就做国际化生意，公司在此之前已经在欧洲布局研发生产基地。
五 | ”昨日白宫消息，美国总统拜登签署一项行政命令，启动一项国家生物技术和生物制造倡议。今日国内CXO概念股领跌，博腾股份最大跌幅近9%。（财联社）NO.5 飞常准APP数据显示，9月13日上午，两架C919先后飞往北京首都国际机场，分别于10时51分和11时24分到达。数据显示，两架C919飞机注册号分别为B-001F和B-001J，于9时6分和9时40分从上海浦东国际机场相继起飞。(新京报)康弘药业（SZ002773，股价15.6元，市值143.4亿元）9月13日午间公告称，子公司济生堂生产的舒肝解郁胶囊获批国家中药二级保护品种。美联新材（SZ300586，股价18.27元，市值95.82亿元）9月13日午间发布公告，公司自主研发的“一种以聚乳酸回收废弃料为载体的彩色母粒及其制备方法”取得发明专利证书。金融街（SZ000402，股价5.68元，市值169.8亿元）9月13日午间公告称，公司董事王开国因个人原因辞去公司第九届董事会董事等一切职务，辞职后不在金融街及其控股子公司担任任何职务。王开国未持有公司股份。志特新材（SZ300986，股价38.59元，市值63.25亿元）9月13日午间发布公告，向不特定对象发行可转换公司债券申请获得深交所受理。常山北明（SZ000158，股价6.15元，市值98.31亿元）9月13日午间公告称，原棉二分公司厂区土地使用权挂牌出让，该地块竞拍起始价为13.95亿元，增价幅度为100万元/次。由于该地块拍卖价格及搬迁支持资金返还时间不确定，此次公开出让对公司本期及期后利润的影响不确定。每日经济新闻返回搜狐，查看更多责任编辑：
